Anand Anandkumar (@anand_bugworks) 's Twitter Profile
Anand Anandkumar

@anand_bugworks

passionate about solving global health problems (focus on Infection, and oncology and empowering the girl child!

ID: 2599291717

linkhttp://www.bugworksresearch.com calendar_today02-07-2014 06:36:23

1,1K Tweet

1,1K Followers

438 Following

Health Policy Watch - Global Health News Reporting (@healthpolicyw) 's Twitter Profile Photo

While more countries are concerned about #AMR than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics. Wellcome Anand Anandkumar Kerry Cullinan healthpolicy-watch.news/more-countries…

Global Antibiotic R&D Partnership (GARDP) (@gardp_amr) 's Twitter Profile Photo

Given the antibacterial pipeline trends, what are the latest R&D recommendations? 💡Develop innovative medicines to combat drug-resistant Gram-negative infections, according to World Health Organization (WHO) We are proud to work with Anand Anandkumar to address this need! iris.who.int/bitstream/hand…?

Given the antibacterial pipeline trends, what are the latest R&D recommendations?

💡Develop innovative medicines to combat drug-resistant Gram-negative infections, according to <a href="/WHO/">World Health Organization (WHO)</a> 

We are proud to work with <a href="/Anand_bugworks/">Anand Anandkumar</a> to address this need!

iris.who.int/bitstream/hand…?
AMR Action Fund (@amractionfund) 's Twitter Profile Photo

New report from Center for Global Development estimates: -#AMR adds excess $66 bn to global costs of hospital treatment - If AMR worsens w/o effective interventions, costs could ⬆️ $159 billion annually by 2050 -Under certain conditions, #AMR shrinks global econ by $1.7 trillion

Global Antibiotic R&D Partnership (GARDP) (@gardp_amr) 's Twitter Profile Photo

“We need a bold vision to support LMICs to undertake the R&D to develop new and affordable antibiotics where the biggest burden is. And by doing so, produce the necessary evidence for broader use globally.” Anand Anandkumar #WHS2024

“We need a bold vision to support LMICs to undertake the R&amp;D to develop new and affordable antibiotics where the biggest burden is. And by doing so, produce the necessary evidence for broader use globally.” <a href="/anand_bugworks/">Anand Anandkumar</a> #WHS2024
Damiano de Felice (@damidefelice) 's Twitter Profile Photo

Thanks, #Italy, for your decision to join CARB-X and support our mission with USD 21 million over three years. We can #StopSuperbugs together!

Anand Anandkumar (@anand_bugworks) 's Twitter Profile Photo

Dear Manjula Aravind Limbavali madam, when can residents of Thubarahalli meet with you to discuss the impossible traffic situation (from Vartur Kodi to Kundanahalli junction). I see ambulances being stuck almost everyday. The roads are pathetic, and we get no support from BBMP. Thanks

Global Antibiotic R&D Partnership (GARDP) (@gardp_amr) 's Twitter Profile Photo

We are grateful to @ICMR and our other partners and supporters in #India. 🙏 India has all the necessary elements to tackle the #AMR crisis in its own borders and offer solutions to the world

We are grateful to @ICMR and our other partners and supporters in #India. 🙏

India has all the necessary elements to tackle the #AMR crisis in its own borders and offer solutions to the world
Manica Balasegaram (@manica_amr) 's Twitter Profile Photo

Excellent article on India’s locally developed new drugs and the game-changing solution they offer to preserve last-resort treatments. We need more innovation and to learn from past mistakes. bbc.com/news/articles/…

Dr. Taslimarif Saiyed (@taslimarif) 's Twitter Profile Photo

We are ecstatic about this! 4 out of 6 Top Indian biotech companies leading the global healthcare revolution from the forefront are C-CAMP startups as per the latest Labiotech.eu survey. labiotech.eu/best-biotech/b… Congrats #Bugworks, Zumutor Biologics Eyestem #Gangagen

Shantha R. Mohan, Ph.D., DTM (@shantharmohan) 's Twitter Profile Photo

I always learn a ton from Kamala's reporting. Well researched and superbly written. Incidentally, Anand Anand Anandkumar, the co-founder and CEO of Bugwork Research, is a fellow CEG alum. Kudos!

C-CAMP (@ccamp_india) 's Twitter Profile Photo

This #WorldCancerDay, CCAMP stands by the theme #UnitedByUnique, highlighting personalised cancer care! Every patient’s experience is unique, and their treatment should be too. C-CAMP is proud to work with 40+ startups advancing cancer screening, diagnostics, therapeutics, and

This #WorldCancerDay, CCAMP stands by the theme #UnitedByUnique, highlighting personalised cancer care!

Every patient’s experience is unique, and their treatment should be too. C-CAMP is proud to work with 40+ startups advancing cancer screening, diagnostics, therapeutics, and
The Trinity Challenge (@trinitychall) 's Twitter Profile Photo

Speaker Vasan Sambandamurthy from Anand Anandkumar explaining India's role in the #AntibioticEmergency- "More than 60% of the world's medicines are manufactured in India, India is the pharmacy of the world. We need to know who is buying what antibiotics so we can regulate well."

Speaker <a href="/VasanSambandam1/">Vasan Sambandamurthy</a> from <a href="/anand_bugworks/">Anand Anandkumar</a> explaining India's role in the #AntibioticEmergency- "More than 60% of the world's medicines are manufactured in India, India is the pharmacy of the world. We need to know who is buying what antibiotics so we can regulate well."
C-CAMP (@ccamp_india) 's Twitter Profile Photo

🎉 CCAMP startup Bugworks has clinched the Forbes India National Award in the Emerging Innovation category for their pioneering work in deep science. Incubated at CCAMP, Bugworks is a clinical-stage biopharmaceutical company developing affordable, accessible, and novel therapies

🎉 CCAMP startup Bugworks has clinched the <a href="/ForbesIndia/">Forbes India</a> National Award in the Emerging Innovation category for their pioneering work in deep science.

Incubated at CCAMP, Bugworks is a clinical-stage biopharmaceutical company developing affordable, accessible, and novel therapies